Morieri, Mario Luca
Lamacchia, Olga
Manzato, Enzo
Giaccari, Andrea
Avogaro, Angelo
,
Amoresano, Lucio
Angotti, Stefania
Bartone, Laura
Caraffa, Francesco
Carboni, Antonello
Carro, Stefano
Cervone, Silvestre
Clerico, Alessandra
Console, Ida
Conti, Danilo Mario
D’Addato, Sergio
de Bellis, Alessandra
de Meo, Francesco
di Carlo, Alberto
di Cianni, Graziano
di Giovanni, Giuseppe
di Lembo, Sergio
Diacono, Fabrizio
Dolcino, Mara
Elia, Giovanni
Elli, Paolo
Fatone, Cristina
Galli, Angelica
Galluzzo, Giovanni
Garzaniti, Adriana
Ghelardi, Renata
Giacchini, Anna
Giunta, Loretta
Golia, Francesco
Gregorio, Franco
Ierna, Dario
Lampitella, Antonio
Luciano, Antonio
Maffettone, Ada
Mancini, Raffaele
Mangone, Ida
Mantovani, Linneo Enzo
Marangoni, Alberto
Marelli, Giuseppe
Marin, Narciso
Marino, Gennaro
Mastromatteo, Eugenio
Mazziotti, Gaetano
Me, Elisa
Memoli, Giuseppe
Menicatti, Laura Silvia Maria
Moffa, Simona
Moise’, Manuela
Monaco, Fabrizio
Morgante, Sara Nazzarena
Pellicano, Francesca
Petraroli, Ettore
Piersanti, Deamaria
Pipitone, Antonino
Puglisi, Susanna
Rinaldi, Maura
Rizzo, Mario
Rosco, Maura
Scollo, Giampaolo
Simioni, Natalino
Squadrone, Mariarosaria
Sturniolo, Giacomo
Tedeschi, Anna
Tizio, Biagio
Ugolotti, Diletta
Valente, Livio
Vinci, Carmela
Zenoni, Luca
Zenti, Maria Grazia
Funding for this research was provided by:
The study was unconditionally supported by Neopharmed Gentili
Article History
Received: 23 December 2021
Accepted: 5 April 2022
First Online: 26 April 2022
Change Date: 13 May 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12933-022-01515-7
Declarations
:
: The study conforms to the ethical guidelines of the 1975 Declaration of Helsinki, completely anonymized data were analyzed and based on National and International regulations, a waiver was applied to the requirement for patients' informed consent.
: Not applicable.
: MLM received lecture or advisory fees or grant support from Mylan, SlaPharma, Servier, Lilly, MSD, Novo Nordisk, and was unconditionally supported by LatoC Srl for conducting the analyses of the data of the current work and writing the manuscript. OL received speaker or advisory board fees from Eli-Lilly and NovoNordisk, research grants from Astra Zeneca. EM none. AG has received honoraria or consulting fees from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, MSD, and Sanofi, and research funding from AstraZeneca. AA received research grants, lecture or advisory board fees from Merck Sharp & Dome, AstraZeneca, Novartis, Boeringher-Ingelheim, Sanofi, Mediolanum, Janssen, Novo Nordisk, Lilly, Servier, and Takeda.